baber/WOPTO huggingface dataset:
Patent AU-557204-B2 (AU)
Title: Wettable polyolefin fibres
Inventor: SAWYER LAWRENCE H
IPC: A61L15/00
Filed: 1985-02-08
Granted: 1986-12-11
Abstract: Wettable fibers and/or filaments are prepared from olefin polymers, especially linear low density copolymer (LLDPE), by incorporating into said olefin polymer at least one wetting agent of the group comprising (a) an alkyoxylated alkyl phenol along with a mixed mono-, di-, and/or triglyceride, (b) a polyoxalkylene fatty acid ester, or (c) a combination of (b) and any or all parts of (a).
Patent AU-704457-B2 (AU)
Title: Method and apparatus for processing fluids
Inventor: WALL ROBERT
IPC: B04B5/04
Filed: 1995-10-17
Granted: 1999-04-22
Abstract: Embodiments of the present invention feature a multilchambered cuvette having a first movement pattern and a second movement pattern, the first movement pattern comprises a stationary position and a rotation about a circular path. The second movement pattern comprises a rocking motion. The cuvette uses the first movement of fluid between chambers and a second movement pattern to effect mixing and incubation. The cuvette features a unitary housing having an opening over the first and second compartments to allow viewing and access.
Patent AU-709580-B2 (AU)
Title: Preservative systems for pharmaceutical compositions containing cyclodextrins
Inventor: CASTILLO ERNESTO J
IPC: A61K47/40
Filed: 1997-08-08
Granted: 1999-09-02
Abstract: PCT No. PCT/US97/14119 Sec. 371 Date Mar. 10, 1998 Sec. 102(e) Date Mar. 10, 1998 PCT Filed Aug. 8, 1997 PCT Pub. No. WO98/06381 PCT Pub. Date Feb. 19, 1998Disclosed are preservative systems useful in aqueous pharmaceutical compositions containing an active agent and a cyclodextrin. The preservative systems comprise boric acid and one or more compounds selected from the group consisting of C16 benzalkonium halide compounds, polymeric quatemary ammonium compounds, and quatemary ammonium alkylene glycol phospholipid derivatives of the following structure where a+b=3; R1 is C8-C22 alkyl or alkene; X is NH, O, or CH2; R2 is C2-C6 alkyl; each R3 is independently C1-C12 alkyl or alkene; and Y is nothing or C1-C6 alkyl or alkene; and pharmaceutically acceptable salts thereof.
Patent AU-711367-B2 (AU)
Title: Lipid-splitting enzyme
Inventor: HERRMANN DIETER
IPC: A61K47/48
Filed: 1995-11-09
Granted: 1999-10-14
Abstract: A membranous enzyme not yet described in the state-of-the-art can be extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. Also disclosed is the use of substrates of this enzyme to prepare medicaments that contain these substrates as pharmaceutical active substance. These medicaments are useful to direct pharmacologically active substances to target cells and to enrich target cells with said substances. Also disclosed are in-vitro research systems containing this enzyme used to detect other substrates of this enzyme.
Patent AU-593524-B2 (AU)
Title: Expression plasmids useful in B. subtilis
Inventor: BEPPU TERUHIKO
IPC: C12N15/59
Filed: 1985-03-07
Granted: 1990-02-15
Abstract: A new vector system is described for expression of prochymosin in B. subtilis. The vector system includes the prochymosin encoding gene and an erythromycin resistant promotor and can be integrated into a B. subtilis host organism as an expression plasmid adapted for transformation.
Patent AU-696527-B2 (AU)
Title: Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
Inventor: HALLINAN ANN E
IPC: C07C257/14
Filed: 1995-11-08
Granted: 1998-09-10
Abstract: Compounds having formula (I) and pharmaceutically acceptable salts thereof, wherein B is NR<5>R<11>, wherein R<5> is selected from the group consisting of hydrogen, lower alkyl, lower alkenyl, lower alkynyl and aryl, and R<11> is selected from a 3 to 8 member heterocyclyl radical in which at least one member of the ring is carbon and in which 1 to about 4 members are heteroatoms independently selected from oxygen, nitrogen and sulfur and said heterocyclyl radical may be optionally substituted, useful as nitric oxide synthase inhibitors. <CHEM>
Patent AU-654442-B2 (AU)
Title: Vessel having a plurality of chambers
Inventor: INOUE FUJIO
IPC: A61J1/00
Filed: 1993-04-28
Granted: 1994-11-03
Abstract: A vessel having a plurality of chambers for use mainly in the medical field, wherein the interior of the main body of a flexible plastic vessel is partitioned into a plurality of chambers by use of a partitioning means permitting suitable communication between the chambers, out of respective vessel portions of the main body of the plastic vessel, which constitute the plurality of chambers, at least one vessel portion has no cover and at least another vessel portion has a cover, said cover covering the peripheral surface of said vessel portion through a tightly sealed space portion and being formed of flexible film having moisture-proof and gas barrier properties, so that the easily disposable vessel having the plurality of chambers, which is inexpensive and high in quality and performance can be provided. <IMAGE>
Patent AU-670293-B2 (AU)
Title: An absorbent body for an absorbent article
Inventor: GUIDOTTI TED
IPC: A61F13/15
Filed: 1993-04-21
Granted: 1996-07-11
Abstract: PCT No. PCT/SE93/00348 Sec. 371 Date Oct. 14, 1994 Sec. 102(e) Date Oct. 14, 1994 PCT Filed Apr. 21, 1993 PCT Pub. No. WO93/21882 PCT Pub. Date Nov. 11, 1993An absorbent body intended to form the absorbent element of an absorbent article, such as a diaper, an incontinence guard or a sanitary napkin, includes a first fibre-based absorbent layer which lies proximal to the wearer in use, and a second, fibre-based absorbent layer which is intended to lie distal from the wearer in use, this second layer having a high liquid-dispersing ability. An absorbent body exhibiting particularly good absorption properties has been obtained by including in the first layer (16) a superabsorbent material (18) of high gel-strength and by mixing this superabsorbent essentially uniformly in the fibre material within at least one area of the layer, and by including between the fibre layers (17a, 17b) of the second layer (17) a layer (20) of superabsorbent material.
Patent AU-689010-B2 (AU)
Title: Heat-transfer concentrate, method of manufacturing it and its use, as well as a latent-heat accumulator making use of the concentrate
Inventor: DAUME JOCHEN
IPC: C09K5/06
Filed: 1995-12-06
Granted: 1998-03-19
Abstract: PCT No. PCT/EP95/04791 Sec. 371 Date Oct. 20, 1997 Sec. 102(e) Date Oct. 20, 1997 PCT Filed Dec. 6, 1995 PCT Pub. No. WO96/21706 PCT Pub. Date Jul. 18, 1996A heat-transfer concentrate comprising a storage-stable dispersion of a heat-storage medium and gallium adsorbed onto a solid having either a particle diameter of 1 to 3 um or a pore diameter of 0.2 to 0.6 nm, or both, is provided. The invention also provides a method of manufacture for the concentrate, and a heat-transfer mixture comprising the heat-transfer concentrate and another heat-storage medium. The invention further provides methods of using the heat-transfer mixture to store and convey heat in reactors with heat exchangers, as well as methods of use in heat pumps and as a thermochemical energy-storage medium.
Patent AU-759264-B2 (AU)
Title: Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
Inventor: FLEISCHER WOLFGANG
IPC: A61K9/00
Filed: 1999-05-27
Granted: 2003-04-10
Abstract: Use of an anti-inflammatory agent such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the lower respiratory tract which are susceptible to the administration of such agents.
Patent AU-725802-B2 (AU)
Title: Production of familial, non-modular, plural colour patterns on a moving substrate
Inventor: DAVIES MARK JOHN
IPC: B05D1/26
Filed: 1997-10-13
Granted: 2000-10-19
Abstract: A method of continuously producing a continuous paint coat of substantially constant, pre-determined thickness, and displaying a plural colour, familial, non-modular pattern, on a surface of a moving substrate, comprising the steps of depositing at least two discontinuous, randomly patchy, differently coloured, component paint deposits, at a predetermined, constant, long term deposition rate for each component deposit in terms of the volume of paint per unit area of the surface, within a single stationary target area of the surface, or within stationary target areas of the surface respectively associated with the component deposits and at least partly aligned in the direction of movement of the substrate, and thereafter spreading and smoothing the component paint deposits carried by the substrate from the target area or areas, to form the continuous coat.
Patent AU-569631-B2 (AU)
Title: Production of iron oxide catalyst
Inventor: JENNINGS JAMES ROBERT
IPC: B01J23/74
Filed: 1985-07-31
Granted: 1988-02-11
Abstract: A pelleted iron oxide catalyst precursor wherein the iron oxide has an O/Fe atomic ratio in the range 1.2 to 1.4, a high surface area and a density of at least 2.6 g.cm-3. The precursor may be made by de-oxidizing, by heating in the presence of a steam/hydrogen mixture, an iron oxide composition made by precipitation and calcination, followed by pelleting after-de-oxidation.
Patent AU-677017-B2 (AU)
Title: Biotinylated chemiluminescent labels, and their conjugates, assays and assay kits
Inventor: REMAKRISHNAN KASTOORIRANGANATH
IPC: G01N33/532
Filed: 1993-08-19
Granted: 1997-04-10
Abstract: A unique class of chemiluminescent labels containing biotin substitution that are suitable for chemiluminescent assays using inter alia a streptavidin and/or avidin conjugate. The chemiluminescent labels of the invention have the ability to bind to streptavidin and/or avidin per se or to streptavidin and/or avidin conjugated with an analyte. Label structures are disclosed that have hydrolytic stability to meet the most demanding commercial assay conditions. The invention encompasses conjugates containing associated versions of the labeling compounds, assays and kits for performing such assay utilizing the conjugates.
Patent AU-631405-B2 (AU)
Title: Method for preparing intermediates for the synthesis of steroid side chains in optically active form
IPC: C07C315/02
Filed: 1990-02-16
Granted: 1992-11-26
Abstract: This invention provides a novel method for the preparation of optically active arylalkylsulfone derivatives, having a chiral center in the alkyl moiety in either the (R)- or the (S)-configuration. These optically active sulfones find use in the stereospecific synthesis of steroid or vitamin D compounds having chiral center at either carbon 24 or carbon 25 of the side chain.
Patent AU-527118-B2 (AU)
Title: Gelated micronutrient fertilizers, process for their manufacture and their use for plant fertilization
Inventor: MEYER KLAUS
IPC: C05D9/02
Filed: 1979-10-26
Granted: 1983-02-17
Abstract: Water-soluble gelated micronutrient fertilizers containing 55 to 89% by weight of water soluble compounds of micronutrients of which 25 to 100 mol % of the cations are present in complexed form, 2 to 7% by weight of ammonium nitrogen as macronutrient, 2 to 18% by weight of polyglycol ether having at least 9 ethylene oxide (EO) units and/or water-soluble polyglycol ether derivatives having at least 8 EO units in the molecule and 7 to 20% by weight of water, process for their manufacture and their use for plant fertilization.
Patent AU-653318-B2 (AU)
Title: Cardiac biopotential analysis system and method
Inventor: CHAMOUN NASSIB G
IPC: A61B10/00
Filed: 1990-03-13
Granted: 1994-09-29
Abstract: Disclosed is a cardiac biopotential analysis system and method for detecting and quantifying in a noninvasive manner nonlinear dynamic patterns of depolarization and repolarization on a beat to beat basis in real time using bispectral analysis. A suitable body surface electrode acquires the signal from a region of interest. The signal is then amplified, digitized, and transmitted to a host microcomputer where an arrhythmia-free QRST complex is chosen interactively. Using standard cross-correlation methods a suitable number of complexes are extracted from the record. The extracted complexes are used to compute bispectral parameters using a frequency domain or a parametric based approach. A reference clinical database is used to identify frequency pairs most sensitive to particular interventions or diagnostic states of interest. The values at these frequency pairs are then extracted from the patient's bispectral arrays. The ensemble of values for the particular diagnostic determination under consideration is used to compute a single value index which serves as the diagnostic criterion by which the patient's state is judged. In this way the quantification of nonlinear dynamic properties of the frequency structure of the QRST yields information about the presence and extent of coronary artery disease (CAD), myocardial ischemia, cardiac electrical stability, risk of malignant ventricular arrhydthmia, site(s) of origin of malignant arrhythmias, extent of malignancy of arrhythmias, degree of antiarrhythmic drug efficacy, neural and humoral inputs to the heart, pump function/ejection fraction, and ongoing organ rejection in cardiac transplant patients.
Patent AU-536900-B2 (AU)
Title: Air/fuel ratio devicer
Inventor: ZINIADES EMMANUEL JOHN
IPC: F02M23/08
Filed: 1979-11-27
Granted: 1984-05-31
Abstract: The invention provides a method of, and apparatus for, controlling the fuel to air ratio of the fuel mixture to an internal combustion engine which includes a fuel mixture feed system having a known type of carburettor and has the object of increasing the range of engine speeds and operating conditions in which the fuel to air ratio approaches the optimum value in comparison with the ranges achieved by carburettors of the type normally used. In the method the fuel mixture is supplemented with air and exhaust gas by utilizing pressure controlled air and exhaust gas valves (7,8) operated by pressure changes in the fuel feed system and/or intake manifold of the engine so that the valves open when the fuel to air ratio of the fuel mixture supplied by the carburettor is in excess of a predetermined value.
Patent AU-587808-B2 (AU)
Title: Improvements in weapon training systems
Inventor: LACINY RICHARD WENCESLAS
IPC: F41G3/26
Filed: 1986-03-24
Granted: 1989-08-31
Abstract: In a weapons training simulator, laser radiation is output via optics (28) to simulate the firing of a round, and reflected radiation received via a conjugate path to assess the effectiveness of the shot. In the event of a miss a scan of the target area is required to provide fall of shot information. The scan is performed by controlled movement of the output faces of fibre optics (23, 24, 25) flexibly coupling to fixed sources (20, 21. 22) and of the input face of a fibre optic (200) flexibly coupling to a fixed detector (201). The problem of the bulk and inertia of prior art systems is improved by the remote location of lasers, drive and control, which may be conveniently separated for service or replacement without disturbing the optically aligned input and output faces. A further improvement is that vertically aligned multiple sources may be employed without undue weight penalty, yielding elevation information from a lateral scan.
Patent AU-527191-B2 (AU)
Title: Sound synthesizer
Inventor: PFEIFFER RANDALL R
IPC: G10H7/00
Filed: 1980-02-29
Granted: 1983-02-17
Abstract: An electronic circuit is disclosed which is capable of producing synthesized sounds under the control of a microprocessor or other type computer. A plurality of switch inputs are provided whereby the sound to be produced can be selected. The processor, under program control, then generates such sounds utilizing one or more basic waveforms stored in a memory. These basic waveforms are modified in specified ways and then outputted through an I/O device to a digital to analog converter for application to an audio system. Eight input control lines to the microprocessor also feed an 8-input NAND gate, such that a momentary change of the normally-high control inputs will cause the NAND gate to activate an interrupt request.
Patent AU-703839-B2 (AU)
Title: Data management and distribution system and method for an electronic television program guide
Inventor: THOMAS WILLIAM
IPC: H04H20/00
Filed: 1996-04-26
Granted: 1999-04-01
Abstract: A data management and distribution system for an electronic program guide ("EPG") for television programs comprising an automated data collection subsystem, a manual entry and correction subsystem, a database validation subsystem, an edition generation subsystem, a configuration subsystem, and a status and control subsystem. The system may further comprise a feed generation subsystem if one of more of the EPG providers supported by the EPG distributor requires a live feed of data. The automated data collection subsystem collects EPG data from multiple source sin various formats, filters the data based on the needs of the EPG providers supported, and places the data in a centralised database in a form suitable to support the different environmental contexts of the EPG providers. The manual entry and correction subsystem permits the EPG distributor to make manual correction, additions, and deletion to the data stored in the database. The database validation subsystem verifies the data stored in the database in accordance with designated verification options. The edition generation subsystem generates the different editions of the PEG for the different EPG providers supported by the EPG distributor. The configuration subsystem receives information from the various EPG providers and furnishes this information to the other subsystems which utilise the information in performing their respective tasks. The status and control subsystem monitors the operation of the data management and distribution system as a whole. The various feeds and editions are then transmitted to the EPG providers by eg satellite, wire, cable, etc. The EPG providers receive the feeds and editions and use them to provide one or both of a dedicated channel EPG and interactive EPG to subscribers.
Patent AU-756351-B2 (AU)
Title: Mixing apparatus
Inventor: FOLESTAD STAFFAN
IPC: B01F23/00
Filed: 1999-07-29
Granted: 2003-01-09
Abstract: A mixing apparatus for and a method of supplying a mixture having a required homogeneity, the mixing apparatus comprising: a mixing device (1; 101) for mixing a plurality of materials, the mixing device (1; 101) including a mixing vessel (7; 107) and having at least one inlet port (8, 9; 108, 109, 110) and an outlet port (11; 111); a supply line (19; 119) connected to the outlet port (11; 111) of the mixing device (1; 101); and at least one measuring device (23, 25, 27; 123, 125, 127) for measuring on-line at at least one point in the supply line (19; 119) the composition of the mixed material passing in use through the supply line (19; 119).
Patent AU-713993-B2 (AU)
Title: Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
Inventor: KORNBERG BRIAN EDWARD
IPC: A61P25/00
Filed: 1996-05-13
Granted: 1999-12-16
Abstract: A novel series of substituted quinoxaline 2,3-diones of Formula I    <IMAGE>  I  useful as neuroprotective agents are taught. Novel intermediates, processes of preparation, and pharmaceutical compositions containing the compounds are also taught. The compounds are glutamate antagonists and are useful in the treatment of stroke, cerebral ischemia, or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia, seizure disorders, pain, Alzheimer's, Parkinson's, and Huntington's Diseases.
Patent AU-696841-B2 (AU)
Title: Wireless personal local area network
Inventor: MAHANY RONALD L
IPC: H04L29/06
Filed: 1993-12-23
Granted: 1998-09-17
Abstract: A transceiver apparatus (110) for creating a wireless personal local area network between a computer terminal (7) and one or more peripheral devices (9, 13, 23). A separate transceiver (110) is connected to the computer terminal (7) and to each peripheral device (9, 13, 23). The transceivers (110) can be connected to the terminal (7) or the peripheral devices (9, 13, 23) either internally or externally. A low power radio (112) is used to communicate information between the computer terminal (7) and the peripheral devices (9, 13, 23). Different transceivers (110) can be used for modifying the carrier frequency and power of the local area network. A microprocessor (120) is located inside each transceiver (110) and controls the information flow of the transceiver including the communication protocol which allows each device (7, 9, 13, 23) to know if other devices (7, 9, 13, 23) are communicating, which devices (7, 9, 13, 23) are being communicated to, and selectively address the peripheral devices (9, 13, 23). An Idle Sense communication protocol is used for information transfer between the computer terminal (7) and the peripheral devices (9, 13, 23).
Patent AU-591145-B2 (AU)
Title: Virus vaccine with deletion of an antigen of the wild-type virus
Inventor: POST LEONARD E
IPC: A01N63/00
Filed: 1986-06-17
Granted: 1989-11-30
Abstract: Herpesvirus vaccine comprises a properly incapacitated virus having a deletion for a gene encoding a secreted glycoprotein which allows the serological distinction between the vaccine virus and its wild-type progenitor virus. The virus may be e.g. pseudorabies virus, Marek's disease virus or infectious bovine rhinotracheitis virus. Distinguishing between animals infected with a virus and animals vaccinated with a virus comprises vaccinating animals susceptible to the virus with a vaccine comprising the virus having a deletion for at least one gene encoding an antigen of the wild-type progenitor virus, and then serologically distinguishing between such vaccinated animals and those infected with virulent virus without sacrificing the animal.
Patent AU-699055-B2 (AU)
Title: Process for making liposome preparation
Inventor: ALVING CARL L
IPC: A61K9/127
Filed: 1996-06-06
Granted: 1998-11-19
Abstract: A process for making a liposome preparation comprised of liposomes that contain an encapsulated material is disclosed. The process comprises (A) providing a plurality of portions of a lipid or liposome formulation; (B) hydrating each of the plurality of portions with a solution comprising a material to be encapsulated; and (C) combining each of the plurality of portions to form a single liposome preparation. The liposome preparations can be used for drug delivery or as vaccines.